Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Am J Obstet Gynecol. 2010 Apr 24;203(2):162.e1–162.e8. doi: 10.1016/j.ajog.2010.02.056

Figure 2. Representative dose-response curves following exposure to docetaxel and carboplatin + docetaxel (upper panel) versus paclitaxel and carboplatin + paclitaxel (lower panel) in USPC-ARK1 primary cell line.

Figure 2

Survival was assessed by ChemoFx. Each point on the cell line graph represents the mean of 8 to 10 estimations ± SE. Average IC50 values, for each of the cell lines when treated with the single agent or the combination are reported in Table 6.